378 related articles for article (PubMed ID: 22503440)
1. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.
Gao HM; Zhou H; Hong JS
Trends Pharmacol Sci; 2012 Jun; 33(6):295-303. PubMed ID: 22503440
[TBL] [Abstract][Full Text] [Related]
2. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
3. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes.
Noh KM; Koh JY
J Neurosci; 2000 Dec; 20(23):RC111. PubMed ID: 11090611
[TBL] [Abstract][Full Text] [Related]
4. Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury.
Zhang QG; Laird MD; Han D; Nguyen K; Scott E; Dong Y; Dhandapani KM; Brann DW
PLoS One; 2012; 7(4):e34504. PubMed ID: 22485176
[TBL] [Abstract][Full Text] [Related]
5. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Drummond GR; Selemidis S; Griendling KK; Sobey CG
Nat Rev Drug Discov; 2011 Jun; 10(6):453-71. PubMed ID: 21629295
[TBL] [Abstract][Full Text] [Related]
6. Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes.
Kowluru A; Kowluru RA
Biochem Pharmacol; 2014 Apr; 88(3):275-83. PubMed ID: 24462914
[TBL] [Abstract][Full Text] [Related]
7. Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.
Musicki B; Liu T; Sezen SF; Burnett AL
J Sex Med; 2012 Aug; 9(8):1980-7. PubMed ID: 22620981
[TBL] [Abstract][Full Text] [Related]
8. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
[No Abstract] [Full Text] [Related]
10. A conserved region between the TPR and activation domains of p67phox participates in activation of the phagocyte NADPH oxidase.
Maehara Y; Miyano K; Yuzawa S; Akimoto R; Takeya R; Sumimoto H
J Biol Chem; 2010 Oct; 285(41):31435-45. PubMed ID: 20679349
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes.
Geiszt M; Lekstrom K; Brenner S; Hewitt SM; Dana R; Malech HL; Leto TL
J Immunol; 2003 Jul; 171(1):299-306. PubMed ID: 12817011
[TBL] [Abstract][Full Text] [Related]
12. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells :a potential atherogenic source of reactive oxygen species.
Meyer JW; Holland JA; Ziegler LM; Chang MM; Beebe G; Schmitt ME
Endothelium; 1999; 7(1):11-22. PubMed ID: 10599557
[TBL] [Abstract][Full Text] [Related]
13. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
Gao HM; Liu B; Hong JS
J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma.
Johnstone JT; Morton PD; Jayakumar AR; Johnstone AL; Gao H; Bracchi-Ricard V; Pearse DD; Norenberg MD; Bethea JR
PLoS One; 2013; 8(11):e80975. PubMed ID: 24260524
[TBL] [Abstract][Full Text] [Related]
15. Targeting NADPH oxidases in vascular pharmacology.
Schramm A; Matusik P; Osmenda G; Guzik TJ
Vascul Pharmacol; 2012; 56(5-6):216-31. PubMed ID: 22405985
[TBL] [Abstract][Full Text] [Related]
16. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
[TBL] [Abstract][Full Text] [Related]
17. NOX inhibitors as a therapeutic strategy for stroke and neurodegenerative disease.
Cairns B; Kim JY; Tang XN; Yenari MA
Curr Drug Targets; 2012 Feb; 13(2):199-206. PubMed ID: 22204319
[TBL] [Abstract][Full Text] [Related]
18. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia.
Kim GS; Jung JE; Niizuma K; Chan PH
J Neurosci; 2009 Nov; 29(47):14779-89. PubMed ID: 19940173
[TBL] [Abstract][Full Text] [Related]
19. Apocynin, a low molecular oral treatment for neurodegenerative disease.
't Hart BA; Copray S; Philippens I
Biomed Res Int; 2014; 2014():298020. PubMed ID: 25140304
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits.
Yu L; Zhen L; Dinauer MC
J Biol Chem; 1997 Oct; 272(43):27288-94. PubMed ID: 9341176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
